Skip to main content
SpringerLink
Log in

Myricetin ameliorates sepsis-associated acute lung injury in a murine sepsis model

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Myricetin belongs to the flavonoid family which is derived from plant source. It is well-known for the anti-inflammatory and anti-oxidative properties yet the clinical use of myricetin awaits further discovery. Acute lung injury (ALI) is commonly caused by sepsis which leads to enormous burden with high morbidity and mortality. In this study, a murine sepsis model was constructed by cecal ligation and puncture (CLP). The indicated dose of myricetin (100 mg/kg) was further administrated intragastrically. The survival rate test indicated that myricetin significantly improved the vitality of CLP-operated mice. The pathological changes in morphology, biomarkers of inflammatory response, oxidative stress response, and mitochondrial damage were further detected. Myricetin showed significant inhibitory effects on these changes in CLP-induced mice. Furthermore, expression levels of transcription factor Nrf2 and heme oxygenase-1 (HO-1) along with DNA binding activity of Nrf2 were analyzed by western blot and EMSA, indicating that myricetin positively regulates the Nrf2/HO-1 pathway in CLP-induced sepsis mice. Murine sepsis models with knockdown of Nrf2 and control were further established and suggested that myricetin might exert protective effects on sepsis lung injury in dependent with Nrf2. Our study provides novel mechanisms for the protective effect of myricetin in sepsis-associated acute lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Ahmed SM, Luo L, Namani A, Wang XJ, Tang X (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta Mol basis Dis 1863:585–597. https://doi.org/10.1016/j.bbadis.2016.11.005

    Article  CAS  PubMed  Google Scholar 

  • Blanco J, Muriel-Bombín A, Sagredo V, Taboada F (2008) Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 12:R158

    Article  Google Scholar 

  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine Chest 101:1644–1655

  • Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4:854–865

    Article  CAS  Google Scholar 

  • Chen Y et al (2017) Heat shock protein A12B protects vascular endothelial cells against sepsis-induced acute lung injury in mice cell. Physiol Biochem 42:156–168. https://doi.org/10.1159/000477308

    Article  CAS  Google Scholar 

  • Fan E (2005) Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA 294:2889

    Article  CAS  Google Scholar 

  • Fan E, Brodie D, Slutsky AS (2018) Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 319:698

    Article  Google Scholar 

  • Fang GS, Perkins GD, Gates S, Young D, Lamb SE (2011) Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379:229–235

    Google Scholar 

  • Frandsen JR, Narayanasamy P (2018) Neuroprotection through flavonoid: enhancement of the glyoxalase pathway. Redox Biol 14:465–473. https://doi.org/10.1016/j.redox.2017.10.015

    Article  CAS  PubMed  Google Scholar 

  • Frank JA, Wray CM, Mcauley DF, Schwendener R, Matthay MA (2006) Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Phys Lung Cell Mol Phys 291:L1191–L1198

    CAS  Google Scholar 

  • Han J-W et al (2019) Suppression of lung inflammation by the ethanol extract of Chung-Sang and the possible role of Nrf2. BMC Complement Altern Med 19:15. https://doi.org/10.1186/s12906-018-2422-3

    Article  PubMed  PubMed Central  Google Scholar 

  • Hong T (2013) Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis. Mol Med Rep 7:565–570

    Article  Google Scholar 

  • Katzenstein ALA, Bloor CM, Leibow AA (1976) Diffuse alveolar damage-the role of oxygen, shock, and related factors. Am J Pathol 85:209–228

    CAS  PubMed  PubMed Central  Google Scholar 

  • Keeley A, Hine P, Nsutebu E (2017) The recognition and management of sepsis and septic shock: a guide for non-intensivists. Postgrad Med J 93:626–634

    Article  Google Scholar 

  • Kim YK, Yeo M, Oh B, Kim H, Yang H, Cho SS, Gil M, Lee K (2017) Tussilagone inhibits the inflammatory response and improves survival in CLP-induced septic mice. Int J Mol Sci 18:E2744. https://doi.org/10.3390/ijms18122744

    Article  CAS  PubMed  Google Scholar 

  • Kumar G, Kumar N, Taneja A, Kaleekal T, Nanchal R (2011) Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140:1223–1231

    Article  Google Scholar 

  • Li JTMA, Su G et al (2015) Unexpected role for adaptive alphabetaTh17 cells in acute respiratory distress syndrome. J Immunol 195:87–95

    Article  CAS  Google Scholar 

  • Mantzarlis K, Tsolaki V, Zakynthinos E (2017) Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies. Oxidative Med Cell Longev 2017:5985209. https://doi.org/10.1155/2017/5985209

    Article  CAS  Google Scholar 

  • Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA (1989) Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 84:1609–1619

    Article  CAS  Google Scholar 

  • Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS (2019) Acute respiratory distress syndrome. Nat Rev Dis Primers 5:18. https://doi.org/10.1038/s41572-019-0069-0

    Article  PubMed  PubMed Central  Google Scholar 

  • McAuley DFLJ, O’Kane CM et al (2014) Simvastatin in the acute respiratory distress syndrome. N Engl J Med 371:1695–1703

    Article  Google Scholar 

  • Perkins GD, Nathani N, McAuley DF, Gao F, Thickett DR (2007) In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 62:36–42

    Article  CAS  Google Scholar 

  • Pipeling MR, Fan E (2010) Therapies for refractory hypoxemia in acute respiratory distress syndrome. Jama 304:2521–2527

    Article  CAS  Google Scholar 

  • Poggi C, Dani C (2018) Sepsis and oxidative stress in the newborn: from pathogenesis to novel therapeutic targets. Oxidative Med Cell Longev 2018:9390140. https://doi.org/10.1155/2018/9390140

    Article  CAS  Google Scholar 

  • Rubenfeld GD, Herridge MS (n.d.) Epidemiology and outcomes of acute lung injury. Chest 131:554–562

  • Rungsung S et al (2018) Luteolin attenuates acute lung injury in experimental mouse model of sepsis. Cytokine 110:333–343. https://doi.org/10.1016/j.cyto.2018.03.042

    Article  CAS  PubMed  Google Scholar 

  • Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Angus DC (2016) Assessment of clinical criteria for sepsis for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:762–774

    Article  CAS  Google Scholar 

  • Singer M et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 315:775–787

    Article  Google Scholar 

  • Spadaro S, Park M, Turrini C, Tunstall T, Thwaites R, Mauri T, Ragazzi R, Ruggeri P, Hansel TT, Caramori G, Volta CA (2019) Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine. J Inflamm (Lond) 16:1. https://doi.org/10.1186/s12950-018-0202-y

    Article  Google Scholar 

  • Sun Y et al (2018) Role of p-MKK7 in myricetin-induced protection against intestinal ischemia/reperfusion injury. Pharmacol Res 129:432–442

    Article  CAS  Google Scholar 

  • Sun J, Sun J, Zhou X (2019) Protective functions of myricetin in LPS-induced cardiomyocytes H9c2 cells injury by regulation of MALAT1. Eur J Med Res 24:20. https://doi.org/10.1186/s40001-019-0378-5

    Article  PubMed  PubMed Central  Google Scholar 

  • Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, Martín-Pellicer A, Lorente JA, Frutos-Vivar F (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1:395–401

    Article  Google Scholar 

  • Tomashefski FJ (2000) Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21:435–466

    Article  Google Scholar 

  • Xu C et al (2019) Biogenic selenium nanoparticles synthesized by Lactobacillus casei ATCC 393 alleviate intestinal epithelial barrier dysfunction caused by oxidative stress via Nrf2 signaling-mediated mitochondrial pathway. Int J Nanomedicine 14:4491–4502. https://doi.org/10.2147/IJN.S199193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yuan X, Liu Y, Hua X et al (2015) Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity. Immunopharmacol Immunotoxicol 37:513–519

    Article  CAS  Google Scholar 

  • Zhang N, Feng H, Liao HH, Chen S, Yang Z, Deng W, Tang QZ (2018) Myricetin attenuated LPS induced cardiac injury in vivo and in vitro. Phytother Res 32:459–470. https://doi.org/10.1002/ptr.5989

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, 050000, Hebei, People’s Republic of China

    Haibo Xu & Xixin Yan

  2. Department of Forensic Pathology, College of Forensic Medicine, Hebei Medical University, Shijiazhuang, 050017, Hebei, People’s Republic of China

    Qian Qi

Authors
  1. Haibo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qian Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xixin Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XY conceived and designed research. HX and QQ conducted experiments and collected data. HX analyzed data. HX and XY wrote the manuscript. All authors read and approved the manuscript.

Besides, we state that all the data were generated in-house, and we did not use a paper mill.

Corresponding author

Correspondence to Xixin Yan.

Ethics declarations

All experiments have been approved by the Institutional Ethics Animal Committee of Hebei Medical University with the official approval number (No. 2020-P009). All operations were conducted according to the guideline for the care and use of laboratory animals.

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, H., Qi, Q. & Yan, X. Myricetin ameliorates sepsis-associated acute lung injury in a murine sepsis model. Naunyn-Schmiedeberg's Arch Pharmacol 394, 165–175 (2021). https://doi.org/10.1007/s00210-020-01880-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-020-01880-8

Keywords

Search

Navigation